24 March 2020

Fight against COVID-19 fraud is new investigation priority of the US Department of Justice

The US Department of Justice (DOJ) has directed all US Attorneys to actively detect, deter and punish misconduct related to the COVID-19 Pandemic.

We live in challenging times. As if keeping the spreading Corona virus at bay were the only threat, more and more crisis profiteers are apparently trying their luck – essentially highlighting the necessity of a vigilant and responsive legal system. Please read our GSK Compliance update.

Print


Press contact
Christine Ström
+49 30 203907-7763
presse@gsk.de

Back

GSK Updates
  • 24 August 2021

    GSK Update: New marketing rules for investment management companies

    Read more
  • 23 June 2021

    GSK Update: The new German law on corporate due diligence in supply chains

    Read more
  • 21 June 2021

    GSK Update: Global data transfer: The new standard data protection clauses – What needs to be done?

    Read more
Contact person

Eric Mayer

Local Partner*

+49 89 288174-73

eric.mayer@gsk.de

* Partner: A partner within the meaning of the partnership company law.
   Local Partner: not a partner within the meaning of the partnership company law.
CO2 Neutral